NCT04218760View on ClinicalTrials.gov

Multiomics After Headache Provocation of People Who Are Unable to Have Headache

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
HeadacheHealthy
Interventions
DRUG

Isosorbide Mononitrate 60 MG Extended Release Oral Tablet [Imdur]

1 tablet Isosorbide Mononitrate 60 mg administrated orally.

OTHER

Blood sample

3 blood samples from a periferal vein, two for RNA and one for metabolomics are taken right before administration of isosorbide mononitrate, 3 hours after administration of isosorbide mononitrate and again 5 hours after administration of isosorbide mononitrate.

Trial Locations (1)

2600

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT04218760 - Multiomics After Headache Provocation of People Who Are Unable to Have Headache | Biotech Hunter | Biotech Hunter